These stocks are in a bear market, but they are poised for gains of up to 68%
- ByMarketWatch-
These stocks are in a bear market, but they are poised for gains of up to 68%
These stocks are in a bear market, but they are poised for gains of up to 68%
Investing.com – U.S. stocks were lower after the close on Tuesday, as losses in the Oil & Gas, Basic Materials and Financials sectors led shares lower. At the close in NYSE, the...
Zimmer Biomet gained the most since November 2020 after the company announced “ZimVie” as the name for the planned spin-off company for the Spine and Dental...
Zimmer Biomet (ZBH) shares rallied 4.7% in the last trading session to close at $147.68. This move can be attributable to notable volume with a higher number of shares being traded...
Daniel Loeb, CEO of Third Point, has a reputation for turning risk into success. His preferred strategy – of going in and cleaning up the mess – has built his
Zimmer Biomet Holdings (NYSE:ZBH), Inc. ZBH continues to gain market share in the Asia Pacific, Europe, the Middle East and Africa (EMEA) regions. However, slower recovery amid the...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Buy | Buy | Buy | Buy |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy | Buy | Buy |
| Summary | Strong Sell | Strong Buy | Strong Buy | Buy | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 146.83 | 147.08 | 145.64 | +0.98 | +0.67% | 64.48M | NASDAQ | |||
| 345.96 | 349.67 | 343.00 | +2.75 | +0.80% | 21.61M | NASDAQ | |||
| 2,824.30 | 2,833.90 | 2,808.00 | +18.6 | +0.66% | 1.04M | NASDAQ | |||
| 44.19 | 44.72 | 44.15 | +0.24 | +0.55% | 18.00M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 20.17 | 20.41 | 19.85 | +0.43 | +2.18% | 7.65M | NYSE | |||
| 224.82 | 225.35 | 218.90 | +5.41 | +2.47% | 24.58M | NASDAQ | |||
| 18.23 | 18.38 | 18.09 | -0.22 | -1.19% | 19.44M | NYSE | |||
| 11.94 | 12.20 | 11.86 | -0.35 | -2.85% | 3.86M | NYSE | |||
| 51.16 | 52.46 | 51.07 | -1.36 | -2.59% | 1.71M | NYSE | |||
| 5.32 | 5.43 | 5.30 | -0.130 | -2.39% | 13.61M | NYSE | |||
| 0.4597 | 0.00 | 0.00 | -0.0074 | -1.58% | 1.28M | NYSE | |||
| 1.45 | 1.45 | 1.32 | +0.0800 | +5.84% | 18.18M | NYSE | |||
| 27.19 | 27.29 | 27.02 | +0.18 | +0.67% | 33.98M | NYSE | |||
| 28.77 | 29.19 | 27.67 | +1.34 | +4.89% | 59.74M | NYSE |
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas and Global Businesses, consisting principally of the United States and other North, Central and South American markets; Europe, Middle East and Africa (EMEA), consisting principally of France, Germany, Italy, Spain and the United Kingdom, and Asia Pacific, consisting primarily of Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong and Malaysia.